心血管疾病中的纤维细胞生长因子
Hideaki Morita1, Masaaki Hoshiga1
1Department of Cardiology, Osaka Medical and Pharmaceutical University.
Journal of atherosclerosis and thrombosis
|August 21, 2024
概括
纤维细胞生长因子 (FGFs) 在治疗心血管疾病 (CVD) 和代谢障碍方面表现有前途. 对FGF机制的进一步研究可能会导致对心血管疾病的新诊断和治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 尽管在风险因素管理方面取得了进展,心血管疾病 (CVD) 仍然是一个重大的健康问题.
- 纤维细胞生长因子 (FGF) 正在成为心血管疾病和代谢条件的发展和潜在治疗的关键因素.
研究的目的:
- 审查目前对FGF在心血管健康和代谢调节中的作用的理解.
- 探索FGFs的治疗和诊断潜力,包括FGF1,FGF2,FGF4和FGF19亚家族.
主要方法:
- 对前临床研究和早期临床试验的审查,涉及FGF用于心血管和代谢应用.
- 分析FGF机制,包括治疗性血管生成和内分泌信号通路.
主要成果:
- FGF1,FGF2和FGF4在冠状动脉和下肢动脉疾病等疾病中显示出治疗性血管生成的潜力.
- FGF19亚家族 (FGF19,FGF21,FGF23) 在新陈代谢中起着关键作用,在治疗新陈代谢障碍和作为生物标志物方面具有潜在的应用.
结论:
- FGF对心血管和代谢疾病的新疗法和诊断策略具有重大前景.
- 进一步的研究和临床试验至关重要,以充分阐明FGFs在管理心血管健康和克服当前治疗方法的局限性的潜力.
相关概念视频
Introduction to Fibroblasts
3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


